Min Tang

3.5k total citations · 1 hit paper
71 papers, 2.2k citations indexed

About

Min Tang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Min Tang has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 30 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Min Tang's work include Viral-associated cancers and disorders (25 papers), Lymphoma Diagnosis and Treatment (9 papers) and RNA modifications and cancer (8 papers). Min Tang is often cited by papers focused on Viral-associated cancers and disorders (25 papers), Lymphoma Diagnosis and Treatment (9 papers) and RNA modifications and cancer (8 papers). Min Tang collaborates with scholars based in China, United States and Saudi Arabia. Min Tang's co-authors include Ya Cao, Xiangjian Luo, Zheqiong Tan, Lifang Yang, Namei Li, Ann M. Bode, Can Cheng, Lanbo Xiao, Zigang Dong and Yueshuo Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and FEBS Letters.

In The Last Decade

Min Tang

67 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging roles of lipid metabolism in cancer metastasis

2017 499 citations Xiangjian Luo, Can Cheng et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Min Tang

Since Specialization

Citations

This map shows the geographic impact of Min Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Tang more than expected).

Fields of papers citing papers by Min Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Tang. The network helps show where Min Tang may publish in the future.

Co-authorship network of co-authors of Min Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Min Tang. A scholar is included among the top collaborators of Min Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Tang. Min Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Does the use of proton pump inhibitors lead to an increased risk of dental implant failure? A systematic review and meta-analysis 2025 ·Medicina oral, patología oral y cirugía bucal ·Min Tang, Zhigang Xie	0
2	CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma 2024 ·Cell Death and Disease ·Yueshuo Li, (unknown), Longlong Xie, Feng Shi, Min Tang, Xiangjian Luo, Na Liu, Xudong Hu, Yongwei Zhu, Ann M. Bode, Qiang Gao, Jian Zhou, Jia Fan, Xuejun Li, Ya Cao	7
3	Advances in dual-functional packaging: Visual monitoring of food freshness using plant essential oils and pH-sensitive natural pigments 2024 ·Food Control ·(unknown), Feng Bao, Min Tang, (unknown), Wen Li, Jing Deng, Qinlu Lin, Mingli Yan, Zavuga Zuberi	24
4	Assessing the benefits and safety profile of incorporating poly ADP-ribose polymerase (PARP) inhibitors in the treatment of advanced lung cancer: a thorough systematic review and meta-analysis 2024 ·Frontiers in Pharmacology ·Min Tang, Yue Wang, (unknown), Rui Han, Ran Wang	1
5	Automated Sagittal Skeletal Classification of Children Based on Deep Learning 2023 ·Diagnostics ·Nan Lan, Min Tang, (unknown), (unknown), Na Kang, (unknown), Xuejun Zhang, Xiaojuan Zeng	10
6	Isolated cryptococcosis of a lumbar vertebra in an immunocompetent patient: A case report and literature review 2023 ·Frontiers in Surgery ·(unknown), Min Tang, Xiaojun Zhang, (unknown), Wei Jiang, Jie Hao	1
7	The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis 2022 ·Journal of Gastrointestinal Oncology ·(unknown), (unknown), Yan Zhang, Ping Li, Min Tang, Min‐Bin Chen, Jun Jin	2
8	Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication 2021 ·npj Precision Oncology ·Yueshuo Li, Feng Shi, Jianmin Hu, Longlong Xie, Lin Zhao, Min Tang, Xiangjian Luo, Mao Ye, Hui Zheng, Min Zhou, Na Liu, Ann M. Bode, Jia Fan, Jian Zhou, Qiang Gao, Shuang–Jian Qiu, Wei‐Zhong Wu, Xin Zhang, Weihua Liao, Ya Cao	14
9	Conformational change of adenine nucleotide translocase‐1 mediates cisplatin resistance induced by EBV‐LMP1 2021 ·EMBO Molecular Medicine ·Lin Zhao, Xiangying Deng, Yueshuo Li, Jianmin Hu, Longlong Xie, Feng Shi, Min Tang, Ann M. Bode, Xin Zhang, Weihua Liao, Ya Cao	15
10	Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis 2020 ·Molecular Metabolism ·Feng Shi, (unknown), Jiangjiang Li, Min Tang, Yueshuo Li, Longlong Xie, Lin Zhao, Jianmin Hu, Xiangjian Luo, Min Zhou, Na Liu, Jia Fan, Jian Zhou, Qiang Gao, (unknown), Wei‐Zhong Wu, Xin Zhang, Wei‐Hua Jia, Ann M. Bode, Ya Cao	23
11	Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy 2020 ·Theranostics ·Jianmin Hu, Yueshuo Li, Hongde Li, Feng Shi, Longlong Xie, Lin Zhao, Min Tang, Xiangjian Luo, Wei‐Hua Jia, Jia Fan, Jian Zhou, Qiang Gao, Shuang–Jian Qiu, Wei‐Zhong Wu, Xin Zhang, Weihua Liao, Ann M. Bode, Ya Cao	38
12	PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation 2019 ·Cancer Science ·Qianqian Du, Zheqiong Tan, Feng Shi, Min Tang, Longlong Xie, Lin Zhao, Yueshuo Li, Jianmin Hu, Min Zhou, Ann M. Bode, Xiangjian Luo, Ya Cao	82
13	Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination 2018 ·Cell Death and Disease ·Xiaolan Liu, Yueshuo Li, (unknown), Xinfang Yu, Wei Li, Feng Shi, Xiangjian Luo, Min Tang, Zheqiong Tan, Ann M. Bode, Ya Cao	62
14	Emerging roles of lipid metabolism in cancer metastasis breakdown → 2017 ·Molecular Cancer ·Xiangjian Luo, Can Cheng, Zheqiong Tan, Namei Li, Min Tang, Lifang Yang, Ya Cao	499
15	EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells 2013 ·International Journal of Oncology ·Xiaoqian Ma, Zhijie Xu, Lifang Yang, Lanbo Xiao, Min Tang, Jingchen Lu, San Xu, Yiping Tang, (unknown), Xingming Deng, Lunquan Sun, Ya Cao	15
16	Tyrosylprotein Sulfotransferase-1 and Tyrosine Sulfation of Chemokine Receptor 4 Are Induced by Epstein-Barr Virus Encoded Latent Membrane Protein 1 and Associated with the Metastatic Potential of Human Nasopharyngeal Carcinoma 2013 ·PLoS ONE ·Juan Xu, Xiyun Deng, Min Tang, Lili Li, Lanbo Xiao, Lifang Yang, (unknown), Ann M. Bode, Zigang Dong, Yongguang Tao, Ya Cao	36
17	LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells 2009 ·Molecular Cancer ·Haidan Liu, Hui Zheng, Zhi Duan, Duosha Hu, Ming Li, Sufang Liu, Zijian Li, Xiyun Deng, (unknown), Min Tang, Yongyong Shi, Wei Yi, Ya Cao	39
18	NF‐κB inhibitors induce lytic cytotoxicity in Epstein—Barr virus‐positive nasopharyngeal carcinoma cells 2008 ·Cell Biology International ·(unknown), Hai Wang, (unknown), (unknown), (unknown), Wei Li, Min Tang, Ya Cao	18
19	Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells 2006 ·Molecular Immunology ·Hui Zheng, Ming Li, Wei Ren, Liang Zeng, Haidan Liu, Duosha Hu, Xiyun Deng, Min Tang, Ying Shi, Jianping Gong, Ya Cao	78
20	A Survey of Silhouette Detection Techniques for Non-Photorealistic Rendering 2005 ·(unknown), Min Tang, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact